XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.
S
S

Sonova

Yangiliklar

Reuters - 2 hafta oldin

Sonova drops as Barclays downgrades, saying recent launches priced in

BUZZ-Sonova drops as Barclays downgrades, saying recent launches priced in ** Barclays cuts Sonova SOON.S to "equal-weight" from "overweight", saying the Swiss hearing aid group's most recent launches have already been priced in ** Shares in Sonova are down 1.6% ** Barclays says the company's FY guidance is "achievable", but points to limited catal
S
A
Reuters - 2 hafta oldin

BMW, Kingfisher, Spectris

EUROPE RESEARCH ROUNDUP-BMW, Kingfisher, Spectris Sept 18 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including BMW, Kingfisher and Spectris, on Wednesday. HIGHLIGHTS * BMW BMWG.DE : Citigroup raises to neutral from sell * Entain ENT.L : Berenberg raises target price to 1,030p from 1,020p * Kingfisher KGF.L : Citigroup raises target price to 301p from 292p * Spectris SXS.L : HSBC cuts to hold from buy * Whitbread WTB.L : Goldman Sachs cu
A
A
A
B
B
B
C
C
C
D
D
E
E
G
H
I
K
K
S
S
S
W
A
A
A
E
M
Reuters - 4 hafta oldin

Hearing aid makers slip after Apple rolls out hearing aid features, analysts shrug off threat

Hearing aid makers slip after Apple rolls out hearing aid features, analysts shrug off threat Sept 10 (Reuters) - Shares in European hearing aid makers slipped in early trading on Tuesday after Apple AAPL.O rolled out hearing aid features. Apple said its AirPods Pro 2 could now be "transformed" into a personalized hearing aid via an upcoming software update that would boost specific sounds in real time, including parts of speech or elements within a user's environment.
A
S
A
Reuters - 4 hafta oldin

Banks, energy stocks weigh on European bourses; BMW tumbles

UPDATE 2-Banks, energy stocks weigh on European bourses; BMW tumbles STOXX 600 down 0.5% BMW slumps after cutting profit margin outlook Germany's inflation slowed to 0.2% in August AstraZeneca falls, lung cancer drug trial fails to improve survival Updated at 1615 GMT By Pranav Kashyap and Lisa Pauline Mattackal Sept 10 (Reuters) - European equity markets largely lost ground on Tuesday, weighed by bank and energy stocks as investors tread cautiously ahead of key U.S.
A
A
B
C
C
S
S
A
E
F
U
G
Reuters - 4 hafta oldin

European hearing aid makers slide after Apple rolls out hearing aid features

BUZZ-European hearing aid makers slide after Apple rolls out hearing aid features ** Shares in hearing aid makers slip on Tuesday after Apple AAPL.O rolled out hearing aid features that it has submitted for U.S. regulatory review ** Apple said that its AirPods Pro 2 can be "transformed" into a personalized hearing aid via an upcoming software updat
A
S
A
Reuters - 1 oy oldin

UBS starts Demant with 'buy', cuts Coloplast to 'sell'

BUZZ-UBS starts Demant with 'buy', cuts Coloplast to 'sell' ** UBS initiates coverage of medical devices maker Demant DEMANT.CO with "buy" rating, and downgrades its Danish peer Coloplast COLOb.CO to "sell" from "neutral" ** It sees Demant to deliver a 13% EPS compound annual growth rate (CAGR) for 2024-2028, ahead of both Swiss rival Sonova SOON.S
S
Reuters - 1 oy oldin

Accelleron, BHP, Kingfisher

EUROPE RESEARCH ROUNDUP-Accelleron, BHP, Kingfisher Aug 28 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Accelleron, BHP and Kingfisher, on Wednesday. HIGHLIGHTS * Accelleron ACLN.S : Deutsche Bank raises target price to CHF 42 from CHF 34 * BHP Group BHPB.L : JP Morgan cuts target price to 2,580p from 2,650p * Kingfisher KGF.L : Citigroup cuts to neutral from buy * Vonovia SE VNAn.DE : Citigroup raises target price to EUR 52.80 f
A
A
A
B
B
B
C
C
D
E
I
K
N
P
S
S
S
S
T
V
H
B
D
Reuters - 1 oy oldin

Jefferies says Demant nears valuation trough, ups to 'hold'

BUZZ-Jefferies says Demant nears valuation trough, ups to 'hold' ** Jefferies upgrades Danish hearing aid maker Demant DEMANT.CO to "hold" from "underperform" on low relative valuation, but notes an absence of catalysts for the stock ** It says Demant is nearing a trough in valuation, after Swiss rival Sonova SOON.S outperformed it over the past three months ** Demant's profit warning in July reflects the impact of its brand strategy in the U.S.
S
Reuters - 2 oy oldin

Top of the Street: UCB, Moncler, Sonova, Moncler, Voestalpine

BUZZ-Top of the Street: UCB, Moncler, Sonova, Moncler, Voestalpine A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** JP Morgan raises UCB UCB.BR to "overweight" from "neutral" as it sees the Belgian biotech firm's "superior growth profile" as "significantly" undervalued by the market; cites expected acceleration in Bimzelx growth ** Morgan Stanley downgrades Sonova SOON.S to "underweight" from "equal-weight", flagging the hearing aid maker's EV/EBITA valua
M
S
U
V
V
Reuters - 2 oy oldin

Morgan Stanley upgrades hearing aid maker Demant, cuts peer Sonova

BUZZ-Morgan Stanley upgrades hearing aid maker Demant, cuts peer Sonova ** Morgan Stanley upgrades hearing aid maker Demant DEMANT.CO to "overweight" from "underweight", while downgrading its peer Sonova SOON.S to "underweight" from "equal-weight" ** Sees an attractive entry point for Demant, citing de-risked estimates after the profit warning and
S
Reuters - 2 oy oldin

Admiral, UCB SA, Victrex

EUROPE RESEARCH ROUNDUP-Admiral, UCB SA, Victrex Aug 21 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Admiral, UCB SA and Victrex, on Wednesday. HIGHLIGHTS * Admiral ADML.L : RBC raises target price to 3,550p from 3,400p * Demant A/S DEMANT.CO : Morgan Stanley raises to overweight from underweight * UCB SA UCB.BR : JP Morgan raises to overweight from neutral * Victrex Plc VCTX.L : Jefferies raises to hold from underperform * Watki
A
A
C
H
I
M
N
R
S
S
U
V
V
A
Reuters - 2 oy oldin

Sonova launches hearing aid with real-time AI, first in market

UPDATE 1-Sonova launches hearing aid with real-time AI, first in market Adds share move in paragraph 1, analysts comments in paragraphs 4 and 6 By Amir Orusov and Anastasiia Kozlova Aug 6 (Reuters) - Switzerland's Sonova SOON.S on Tuesday introduced a hearing aid that utilises real-time artificial intelligence to improve speech clarity from background noise, the first such product in the global market, sending its shares 5% higher.
S
A
Reuters - 2 oy oldin

Europe's STOXX 600 edges up in global recovery, earnings relief

UPDATE 2-Europe's STOXX 600 edges up in global recovery, earnings relief For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window German industrial orders swell in ray of hope for weak economy Novo Nordisk logs biggest one-day gain in five months Bayer shares drop after earnings hit by tough farm market Monte dei Paschi di Siena up after raising profit outlook STOXX 600 up 0.3% Updated at 1600 GMT By Pranav Kashyap and Ankika Biswas Aug 6 (Reuter
A
B
R
S
Z
A
M
J
F
S
G
Reuters - 2 oy oldin

Sonova launches hearing aid with real-time AI, first in market

Sonova launches hearing aid with real-time AI, first in market By Amir Orusov and Anastasiia Kozlova Aug 6 (Reuters) - Switzerland's Sonova SOON.S on Tuesday introduced a hearing aid that utilises real-time artificial intelligence to improve speech clarity from background noise, the first such product in the global market. Along with the hearing aid, named Sphere Infinio, Sonova is launching a new Infinio platform.
S
A
Reuters - 2 oy oldin

Sonova: Announces Two New Hearing Aid Platforms, One With Real-Time AI

BRIEF-Sonova: Announces Two New Hearing Aid Platforms, One With Real-Time AI Aug 6 (Reuters) - SONOVA HOLDING AG SOON.S : ANNOUNCES TWO NEW HEARING AID PLATFORMS, INCLUDING FIRST HEARING AID WITH REAL-TIME AI CUSTOMERS CAN EXPECT NEW HEARING AIDS TO BE AVAILABLE FROM AUGUST THIS YEAR Further company coverage: SOON.S (Gdansk Newsroom)
S
Reuters - 2 oy oldin

Top of the Street: Nestle, Anglo American, Bureau Veritas

BUZZ-Top of the Street: Nestle, Anglo American, Bureau Veritas A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Deutsche Bank downgrades Nestle NESN.S to "hold" from "buy", saying the world's biggest packaged food company went "a cut too far" as it trimmed its sales growth outlook on Thursday ** UBS raises British miner Anglo American AAL.L to "buy" from "neutral" as it sees better risk/reward ratio after the stock fell enough following BHP's BHP.AX offer
B
B
N
S
A
M
Reuters - 3 oy oldin

Demant drops after profit warning

BUZZ-Demant drops after profit warning ** Shares in Demant DEMANT.CO fall around 10% to November lows after the Danish hearing aid maker cut its full-year outlook , citing a "significant" loss of market share for the managed care brand ** Demant now forecasts its organic revenue in 2024 to grow 2-4% against 4-8% seen earlier, expecting continuous low growth in the Hearing Aids unit ** It cuts adjusted EBIT guidance to 4.30-4.60 billion Danish crowns ($629-$672 million) from 4.60-5.00 billion cro
S
A

Shartlar

Ommabop aktivlar

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.